Stocks of Nutex Health Inc (NASDAQ:NUTX) traded higher last session on Wall Street, down -12.28% to $0.08.
NUTX stock price is now -28.82% away from the 50-day moving average and -65.86% away from the 200-day moving average. The market capitalization of the company currently stands at $58.58M.
With the price target of $3, Northland Capital recently initiated with Outperform rating for Nutex Health Inc (NASDAQ: NUTX).
In other news, Vo Thomas T., Chief Executive Officer bought 275,200 shares of the company’s stock on Nov 20 ’23. The stock was bought for $62,195 at an average price of $0.23. Upon completion of the transaction, the Chief Executive Officer now directly owns 269,822,776 shares in the company, valued at $21.59 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 17 ’23, Chief Executive Officer Vo Thomas T. bought 224,800 shares of the business’s stock. A total of $51,704 was incurred on buying the stock at an average price of $0.23. This leaves the insider owning 269,547,576 shares of the company worth $21.56 million. A total of 41.51% of the company’s stock is owned by insiders.
During the past 12 months, Nutex Health Inc has had a low of $0.09 and a high of $1.10. As of last week, the company has a debt-to-equity ratio of 4.49, a current ratio of 1.56, and a quick ratio of 1.50. The fifty day moving average price for NUTX is $0.1094 and a two-hundred day moving average price translates $0.2286 for the stock.
The latest earnings results from Nutex Health Inc (NASDAQ: NUTX) was released for Sep, 2023. According to the Health Information Services Company, earnings per share came in at $0, inline with analysts’ expectations of $0. This compares to -$0.04 EPS in the same period last year. The net profit margin was -18.49% and return on equity was -58.21% for NUTX. The company reported revenue of $69.67 million for the quarter, compared to $53.72 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 29.68 percent. For the current quarter, analysts expect NUTX to generate $70.3M in revenue.
